m_and_a
confidence high
sentiment neutral
materiality 0.60
Lipella Pharmaceuticals amends placement agent agreement with Spartan Capital Securities
LIPELLA PHARMACEUTICALS INC.
- Second Amendment removes at-the-market facility restrictions and modifies tail provision to require 10% fee on investments from accredited retail investors within one year of termination.
- Mirror Offering capacity increased to $7,200,000 (including $1,200,000 over-allotment) with registration statements due within 30 days of closings.
- Variable Rate Transaction restrictions reduced to 90 days post-termination or 10 business days after Registration Statement effective date if $6,000,000 of shares sold.
- Company restricted from disposing securities for 90 days after third closing if all shares under that closing are not registered.